Economic indicators · Energy monitor · Government contracts
Healthcare US
42 of 1029 eligible companies show qualifying buying. Comparable-cohort trend: contracting; 39 companies have complete purchase values.
Europe: qualifying net buying. US: qualifying equity P purchases, without netting sales. Market definitions differ.
Buying participation
42 / 1029 eligible companies show qualifying buying in the window
Largest purchases in the window
Gross qualifying purchases (USD), summed per company. Research leads, not recommendations: a company page shows the roles, transaction types and source filings.
What changed?
Compared with 2026-10-12 · 997 same-sector companies present in both snapshots
Common-cohort change
Entered / left buying status
Coverage / classification additions and removals
Buying companies among coverage additions / removals: 4 / 1
Entered buying status (1)
OneMedNet Corp
Left buying status (19)
TENAX THERAPEUTICS, INC. · COOPER COMPANIES, INC. · Lifevantage Corp · AIM ImmunoTech Inc. · IRIDEX CORP · Cytosorbents Corp · CapsoVision, Inc · PetVivo Holdings, Inc. · electroCore, Inc. · TELA Bio, Inc. · Harvard Apparatus Regenerative Technology, Inc. · FRACTYL HEALTH, INC. · Nano-X Imaging Ltd. · Humacyte, Inc. · MAIA Biotechnology, Inc. · Jushi Holdings Inc. · NewAmsterdam Pharma Co N.V. · NEONC TECHNOLOGIES HOLDINGS, INC. · YD Bio Ltd
Buying characteristics
Top three companies’ share of qualifying gross purchase value: —
Companies with purchases: 42 · Multiple buyers: 15 · Repeat buyers on distinct dates: 18
Multiple buyers · 15/42 (35.7%)
Repeat buying · 18/42 (42.9%)
Largest recorded gross purchases: Kodiak Sciences Inc. (USD 156,989,303) · ADARx Pharmaceuticals, Inc. (USD 67,597,610) · Electra Therapeutics, Inc. (USD 39,999,990)
Features overlap. Buyer-days consolidate the same reported buyer and date, not verified independent purchase events. Name variants may remain. Concentration requires complete values; currencies are never mixed.Companies to investigate
| Company | Buying status | Buyers | Buyer-days | Gross purchases | Latest buy |
|---|---|---|---|---|---|
| Kodiak Sciences Inc. KOD | Buying | 1 | 2 | USD 156,989,303 | 2026-09-29 |
| ADARx Pharmaceuticals, Inc. ADRX | Buying | 5 | 5 | USD 67,597,610 | 2026-09-28 |
| Electra Therapeutics, Inc. ETRA | Buying | 2 | 2 | USD 39,999,990 | 2026-09-21 |
| Anteris Technologies Global Corp. AVR | Buying | 1 | 5 | USD 11,694,513 | 2026-10-06 |
| PROTHENA CORP PUBLIC LTD CO PRTA | Buying | 1 | 7 | USD 5,894,603 | 2026-10-14 |
| TRex Bio, Inc. TRXB | Buying | 2 | 2 | USD 3,799,992 | 2026-10-13 |
| Inhibrx Biosciences, Inc. INBX | Buying | 2 | 4 | USD 2,339,194 | 2026-10-14 |
| Orthofix Medical Inc. OFIX | Buying | 1 | 1 | USD 1,683,400 | 2026-09-21 |
| Xenon Pharmaceuticals Inc. XENE | Buying | 2 | 2 | USD 1,681,140 | 2026-09-30 |
| Helus Pharma Inc. HELP | Buying | 2 | 2 | USD 1,385,730 | 2026-09-29 |
| OneMedNet Corp ONMD | Buying | 2 | 2 | USD 999,999 | 2026-10-09 |
| Outset Medical, Inc. OM | Buying | 1 | 2 | USD 870,260 | 2026-10-02 |
| Alpha Cognition Inc. ACOG | Buying | 1 | 3 | USD 436,500 | 2026-10-01 |
| Retension Pharmaceuticals, Inc. RTSN | Buying | 2 | 2 | USD 369,600 | 2026-10-13 |
| CASSAVA SCIENCES INC SAVA | Buying | 1 | 3 | USD 356,328 | 2026-09-30 |
| Grace Therapeutics, Inc. GRCE | Buying | 1 | 12 | USD 337,771 | 2026-10-16 |
| AgomAb Therapeutics NV AGMB | Buying | 3 | 6 | USD 311,170 | 2026-10-08 |
| Galecto, Inc. GLTO | Buying | 1 | 1 | USD 252,875 | 2026-09-25 |
| QTREX Quantum Ltd. QTEX | Buying | 2 | 4 | USD 181,275 | 2026-10-15 |
| Anixa Biosciences Inc ANIX | Buying | 4 | 4 | USD 180,787 | 2026-09-30 |
| Annexon, Inc. ANNX | Buying | 1 | 1 | USD 99,829 | 2026-09-24 |
| VIVOS INC RDGL | Buying | 1 | 1 | USD 99,600 | 2026-09-30 |
| InMed Pharmaceuticals Inc. INM | Buying | 1 | 9 | USD 84,283 | 2026-10-15 |
| Lipocine Inc. LPCN | Buying | 1 | 3 | USD 82,174 | 2026-09-30 |
| BullFrog AI Holdings, Inc. BFRG | Buying | 2 | 2 | USD 71,500 | 2026-09-22 |
| Beyond Air, Inc. XAIR | Buying | 1 | 4 | USD 62,352 | 2026-10-13 |
| Dyne Therapeutics, Inc. DYN | Buying | 1 | 1 | USD 40,000 | 2026-10-02 |
| PRECISION BIOSCIENCES INC DTIL | Buying | 3 | 3 | USD 29,501 | 2026-09-28 |
| PALISADE BIO, INC. PALI | Buying | 1 | 2 | USD 28,800 | 2026-10-02 |
| Compass Therapeutics, Inc. CMPX | Buying | 1 | 2 | USD 21,250 | 2026-10-01 |
| Phio Pharmaceuticals Corp. PHIO | Buying | 3 | 4 | USD 18,975 | 2026-09-29 |
| Neuraxis, INC NRXS | Buying | 3 | 3 | USD 12,260 | 2026-10-08 |
| enGene Therapeutics Inc. ENGN | Buying | 1 | 1 | USD 10,051 | 2026-09-22 |
| Hepion Pharmaceuticals, Inc. HEPA | Buying | 1 | 1 | USD 10,000 | 2026-09-29 |
| NEOGEN CORP NEOG | Buying | 1 | 1 | USD 6,035 | 2026-10-09 |
| Adagene Inc. ADAG | Buying | 1 | 1 | USD 6,000 | 2026-09-23 |
| BioCardia, Inc. BCDA | Buying | 1 | 2 | USD 3,025 | 2026-09-29 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL | Buying | 1 | 1 | USD 2,974 | 2026-09-30 |
| CTT PHARMACEUTICAL HOLDINGS, INC. CTTH | Buying | 1 | 3 | USD 1,418 | 2026-10-06 |
| ProText Mobility, Inc. TXTM | Buying | 1 | 1 | — | 2026-10-06 |
| Pyxis Oncology, Inc. PYXS | Buying | 1 | 1 | — | 2026-10-01 |
| SL Science Holding Ltd SLBT | Buying | 1 | 1 | — | 2026-09-29 |
987 other eligible companies had no qualifying buying in the window
10x Genomics, Inc. · 111, Inc. · 3M CO · 4D Molecular Therapeutics, Inc. · 60 DEGREES PHARMACEUTICALS, INC. · 89bio, Inc. · 908 Devices Inc. · Aardvark Therapeutics, Inc. · ABBOTT LABORATORIES · AbbVie Inc. · AbCellera Biologics Inc. · ABEONA THERAPEUTICS INC. · Absci Corp · AC Immune SA · Acadia Healthcare Company, Inc. · ACADIA PHARMACEUTICALS INC · ACCURAY INC · ACHIEVE LIFE SCIENCES, INC. · Aclarion, Inc. · Aclaris Therapeutics, Inc. · Acrivon Therapeutics, Inc. · Actinium Pharmaceuticals, Inc. · ACTUATE THERAPEUTICS, INC. · Acumen Pharmaceuticals, Inc. · ACURA PHARMACEUTICALS, INC · Adagio Medical Holdings, Inc. · AdaptHealth Corp. · Adaptive Biotechnologies Corp · ADC Therapeutics SA · Addex Therapeutics Ltd. · Addus HomeCare Corp · ADIAL PHARMACEUTICALS, INC. · Adicet Bio, Inc. · Aditxt, Inc. · Adlai Nortye Group Ltd. · ADMA BIOLOGICS, INC. · Advanced Biomed Inc. · Adverum Biotechnologies, Inc. · AEON Biopharma, Inc. · AETHLON MEDICAL INC · AGENUS INC · AGILENT TECHNOLOGIES, INC. · agilon health, inc. · AGIOS PHARMACEUTICALS, INC. · AIM ImmunoTech Inc. · Airsculpt Technologies, Inc. · AKANDA CORP. · Akari Therapeutics Plc · Akebia Therapeutics, Inc. · Akero Therapeutics, Inc. · Aktis Oncology, Inc. · Alamar Biosciences, Inc. · Alaunos Therapeutics, Inc. · Aldeyra Therapeutics, Inc. · Alector, Inc. · ALIGN TECHNOLOGY INC · Alignment Healthcare, Inc. · Alkermes plc. · Allarity Therapeutics, Inc. · Allogene Therapeutics, Inc. · ALLURION TECHNOLOGIES, INC. · ALNYLAM PHARMACEUTICALS, INC. · ALPHA PRO TECH LTD · Alpha Tau Medical Ltd. · Alpha Teknova, Inc. · Alphatec Holdings, Inc. · ALTERITY THERAPEUTICS LTD · Altimmune, Inc. · Alto Neuroscience, Inc. · ALUMIS INC. · ALX ONCOLOGY HOLDINGS INC · Alzamend Neuro, Inc. · AMARIN CORP PLC\UK · AMERICAN SHARED HOSPITAL SERVICES · American Well Corp · AMGEN INC · AMICUS THERAPEUTICS, INC. · Amneal Pharmaceuticals, Inc. · Amphastar Pharmaceuticals, Inc. · Amylyx Pharmaceuticals, Inc. · AN2 Therapeutics, Inc. · ANAPTYSBIO, INC · ANGIODYNAMICS INC · ANI PHARMACEUTICALS INC · Anika Therapeutics, Inc. · Annovis Bio, Inc. · Apellis Pharmaceuticals, Inc. · Apnimed, Inc. · Apogee Therapeutics, Inc. · Apollomics Inc. · Applied Therapeutics, Inc. · Aprea Therapeutics, Inc. · APTARGROUP, INC. · Aptevo Therapeutics Inc. · Aptose Biosciences Inc. · Apyx Medical Corp · Aquestive Therapeutics, Inc. · Arbutus Biopharma Corp · Arcellx, Inc. · Arcus Biosciences, Inc. · Arcutis Biotherapeutics, Inc. · ARDELYX, INC. · Ardent Health, Inc. · Armata Pharmaceuticals, Inc. · ArriVent BioPharma, Inc. · ARROWHEAD PHARMACEUTICALS, INC. · ARS Pharmaceuticals, Inc. · Artiva Biotherapeutics, Inc. · ARTIVION, INC. · ARVINAS, INC. · Ascendis Pharma A/S · ASCENTAGE PHARMA GROUP INTERNATIONAL · Aspira Women's Health Inc. · ASSEMBLY BIOSCIENCES, INC. · Assertio Holdings, Inc. · ASTRAZENECA PLC · Astria Therapeutics, Inc. · ASTROTECH Corp · AtaiBeckley Inc. · Atara Biotherapeutics, Inc. · Atea Pharmaceuticals, Inc. · ATOSSA THERAPEUTICS, INC. · AtriCure, Inc. · Attovia Therapeutics, Inc. · aTYR PHARMA INC · AUNA S.A. · Aura Biosciences, Inc. · Aurinia Pharmaceuticals Inc. · Autolus Therapeutics plc · Autonomix Medical, Inc. · AVADEL PHARMACEUTICALS PLC · Avalo Therapeutics, Inc. · Avalyn Pharma Inc. · AVANOS MEDICAL, INC. · Avantor, Inc. · Aveanna Healthcare Holdings, Inc. · AVENUE THERAPEUTICS, INC. · Avidity Biosciences, Inc. · AVITA Medical, Inc. · Axogen, Inc. · Axsome Therapeutics, Inc. · AYTU BIOPHARMA, INC · Azenta, Inc. · Azitra, Inc. · Barinthus Biotherapeutics plc. · Bausch & Lomb Corp · Bausch Health Companies Inc. · BAXTER INTERNATIONAL INC · Beam Therapeutics Inc. · Beauty Health Co · BECTON DICKINSON & CO · BELITE BIO, INC · Benitec Biopharma Inc. · BeOne Medicines Ltd. · Bespoke Extracts, Inc. · Beta Bionics, Inc. · Bicara Therapeutics Inc. · BICYCLE THERAPEUTICS PLC · BillionToOne, Inc. · BIO-RAD LABORATORIES, INC. · BIO-TECHNE Corp · BioAge Labs, Inc. · BioAtla, Inc. · BIOCRYST PHARMACEUTICALS INC · BIODESIX INC · BIOFORCE NANOSCIENCES HOLDINGS, INC. · Biofrontera Inc. · BIOGEN INC. · Biohaven Ltd. · BIOLIFE SOLUTIONS INC · BIOMARIN PHARMACEUTICAL INC · Biomea Fusion, Inc. · BIOMERICA INC · Bionano Genomics, Inc. · BioNexus Gene Lab Corp · BioNTech SE · BioStem Technologies, Inc. · biote Corp. · Bioventus Inc. · BIOVIE INC. · BioXcel Therapeutics, Inc. · BIOXYTRAN, INC · Black Diamond Therapeutics, Inc. · BlossomHill Therapeutics, Inc. · Bluejay Diagnostics, Inc. · BLUM HOLDINGS, INC. · Bolt Biotherapeutics, Inc. · BOSTON SCIENTIFIC CORP · Boundless Bio, Inc. · BRAINSTORM CELL THERAPEUTICS INC. · Brainsway Ltd. · Braveheart Bio, Inc. · BridgeBio Oncology Therapeutics, Inc. · BridgeBio Pharma, Inc. · BRIGHT MINDS BIOSCIENCES INC. · BrightSpring Health Services, Inc. · BRISTOL MYERS SQUIBB CO · Brookdale Senior Living Inc. · BRUKER CORP · Burning Rock Biotech Ltd · Butterfly Network, Inc. · C4 Therapeutics, Inc. · Cabaletta Bio, Inc. · Cadre Holdings, Inc. · Cadrenal Therapeutics, Inc. · CalciMedica, Inc. · Calidi Biotherapeutics, Inc. · Camp4 Therapeutics Corp · Candel Therapeutics, Inc. · Canopy Growth Corp · Canton Strategic Holdings, Inc. · CapForce Inc. · CAPRICOR THERAPEUTICS, INC. · CapsoVision, Inc · Cardiff Lexington Corp · Cardiff Oncology, Inc. · CARDINAL HEALTH INC · CareDx, Inc. · Caribou Biosciences, Inc. · Caris Life Sciences, Inc. · CARLSMED, INC. · Cartesian Therapeutics, Inc. · CASTLE BIOSCIENCES INC · CATALYST PHARMACEUTICALS, INC. · Catheter Precision, Inc. · CDT Equity Inc. · CEL SCI CORP · Celcuity Inc. · Celldex Therapeutics, Inc. · Cellectar Biosciences, Inc. · Celularity Inc · Cencora, Inc. · CENTENE CORP · Centessa Pharmaceuticals plc · Century Therapeutics, Inc. · Ceribell, Inc. · CERUS CORP · CervoMed Inc. · CG Oncology, Inc. · CHAMPIONS ONCOLOGY, INC. · Charlie's Holdings, Inc. · CHEMED CORP · Chemomab Therapeutics Ltd. · Cidara Therapeutics, Inc. · Cigna Group · Cingulate Inc. · Claritev Corp · Clearmind Medicine Inc. · ClearPoint Neuro, Inc. · Clene Inc. · Climb Bio, Inc. · CLOVER HEALTH INVESTMENTS, CORP. /DE · CNS Pharmaceuticals, Inc. · Co-Diagnostics, Inc. · Cocrystal Pharma, Inc. · Cogent Biosciences, Inc. · COGNITION THERAPEUTICS INC · Coherus Oncology, Inc. · COLLEGIUM PHARMACEUTICAL, INC · CollPlant Biotechnologies Ltd · COMMUNITY HEALTH SYSTEMS INC · COMPASS Pathways plc · COMPUGEN LTD · Concentra Group Holdings Parent, Inc. · Conexeu Sciences Inc. · CONMED Corp · Connect Biopharma Holdings Ltd · Contineum Therapeutics, Inc. · COOPER COMPANIES, INC. · Corbus Pharmaceuticals Holdings, Inc. · CORCEPT THERAPEUTICS INC · CorMedix Inc. · Corvus Pharmaceuticals, Inc. · Cosmos Health Inc. · CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. · CRESCENT BIOPHARMA, INC. · Crinetics Pharmaceuticals, Inc. · CRISPR Therapeutics AG · Cronos Group Inc. · CRYO CELL INTERNATIONAL INC · Cryoport, Inc. · Cue Biopharma, Inc. · Cullinan Therapeutics, Inc. · CUMBERLAND PHARMACEUTICALS INC · CURIS INC · CV Sciences, Inc. · CVRx, Inc. · CVS HEALTH Corp · Cyclerion Therapeutics, Inc. · CYPHERPUNK TECHNOLOGIES INC. · Cytek Biosciences, Inc. · CYTOKINETICS INC · CytoMed Therapeutics Ltd · CytomX Therapeutics, Inc. · Cytosorbents Corp · Dare Bioscience, Inc. · DarioHealth Corp. · DAVITA INC. · Day One Biopharmaceuticals, Inc. · DBV Technologies S.A. · DELCATH SYSTEMS, INC. · Denali Therapeutics Inc. · DENTSPLY SIRONA Inc. · Dermata Therapeutics, Inc. · DEXCOM INC · DiaMedica Therapeutics Inc. · Dianthus Therapeutics, Inc. /DE/ · Disc Medicine, Inc. · DocGo Inc. · Dogwood Therapeutics, Inc. · DYADIC INTERNATIONAL INC · DYNATRONICS CORP · DYNAVAX TECHNOLOGIES CORP · EDAP TMS SA · Edesa Biotech, Inc. · Edgemode, Inc. · Edgewise Therapeutics, Inc. · Editas Medicine, Inc. · Edwards Lifesciences Corp · Eikon Therapeutics, Inc. · Elanco Animal Health Inc · electroCore, Inc. · Electromed, Inc. · Eledon Pharmaceuticals, Inc. · Elevance Health, Inc. · ELI LILLY & Co · Elicio Therapeutics, Inc. · Elite Health Systems Inc. · ELITE PHARMACEUTICALS INC /NV/ · Eloxx Pharmaceuticals, Inc. · ELUTIA INC. · Embecta Corp. · Emergent BioSolutions Inc. · Emmaus Life Sciences, Inc. · ENANTA PHARMACEUTICALS INC · ENCISION INC · Encompass Health Corp · ENDRA Life Sciences Inc. · Enhabit, Inc. · Enliven Therapeutics, Inc. · Enovis CORP · ENSIGN GROUP, INC · Ensysce Biosciences, Inc. · Entera Bio Ltd. · Entrada Therapeutics, Inc. · Enveric Biosciences, Inc. · Envista Holdings Corp · Envoy Medical, Inc. · ENvue Medical, Inc. · enVVeno Medical Corp · Equillium, Inc. · Erasca, Inc. · Ernexa Therapeutics Inc. · Esperion Therapeutics, Inc. · ESTABLISHMENT LABS HOLDINGS INC. · Estrella Immunopharma, Inc. · Eton Pharmaceuticals, Inc. · Evoke Pharma Inc · Evolus, Inc. · Evommune, Inc. · EXACT SCIENCES CORP · EXAGEN INC. · EXELIXIS, INC. · EXICURE, INC. · EXOZYMES INC. · EyePoint, Inc. · FATE THERAPEUTICS INC · FEMASYS INC · FENNEC PHARMACEUTICALS INC. · FibroBiologics, Inc. · First Tracks Biotherapeutics, Inc. · FITLIFE BRANDS, INC. · Foghorn Therapeutics Inc. · FONAR CORP · Forte Biosciences, Inc. · Fortrea Holdings Inc. · Fortress Biotech, Inc. · FRACTYL HEALTH, INC. · Freenome, Inc. · Fulcrum Therapeutics, Inc. · Fulgent Genetics, Inc. · GALECTIN THERAPEUTICS INC · Galera Therapeutics, Inc. · GE HealthCare Technologies Inc. · GeneDx Holdings Corp. · GENELUX Corp · Generate Biomedicines, Inc. · Generation Bio Co. · Genprex, Inc. · GERON CORP · GILEAD SCIENCES, INC. · Ginkgo Bioworks Holdings, Inc. · Glass House Brands Inc. · GLAUKOS Corp · Global Innovative Platforms Inc. · GLOBUS MEDICAL INC · Gossamer Bio, Inc. · GRAIL, Inc. · Greenwich LifeSciences, Inc. · Guardant Health, Inc. · Guardian Pharmacy Services, Inc. · GUIDED THERAPEUTICS INC · GYRE THERAPEUTICS, INC. · HAEMONETICS CORP · HALOZYME THERAPEUTICS, INC. · Harmony Biosciences Holdings, Inc. · HARROW, INC. · Harvard Apparatus Regenerative Technology, Inc. · HARVARD BIOSCIENCE INC · HCA Healthcare, Inc. · HCW Biologics Inc. · Health Catalyst, Inc. · HEALTHCARE SERVICES GROUP INC · HEALTHEQUITY, INC. · HEALTHSTREAM INC · HeartBeam, Inc. · Heartflow, Inc. · HeartSciences Inc. · Hemab Therapeutics Holdings, Inc. · HENRY SCHEIN INC · HERBALIFE LTD. · HERON THERAPEUTICS, INC. /DE/ · Hims & Hers Health, Inc. · HOLOGIC INC · Hongchang International Co., Ltd · Humacyte, Inc. · HUMANA INC · HWH International Inc. · Hyperfine, Inc. · HYPERION DEFI, INC. · IB Acquisition Corp. · iBio, Inc. · IceCure Medical Ltd. · ICON PLC · ICU MEDICAL INC/DE · IDEAYA Biosciences, Inc. · IDEXX LABORATORIES INC /DE · IGC Pharma, Inc. · ILLUMINA, INC. · ImageneBio, Inc. · Immatics N.V. · Immix Biopharma, Inc. · IMMUCELL CORP /DE/ · Immuneering Corp · ImmunityBio, Inc. · Immunocore Holdings plc · Immunome Inc. · Immunovant, Inc. · IMPACT BIOMEDICAL INC. · Imunon, Inc. · IN8BIO, INC. · Incannex Healthcare Inc. · INCYTE CORP · Indaptus Therapeutics, Inc. · Indivior Pharmaceuticals, Inc. · InfuSystem Holdings, Inc · Inhibikase Therapeutics, Inc. · Inhibitor Therapeutics, Inc. · InMode Ltd. · Inmune Bio, Inc. · InnovAge Holding Corp. · Innovative Eyewear Inc · Innoviva, Inc. · Inogen Inc · Inotiv, Inc. · INOVIO PHARMACEUTICALS, INC. · Insight Molecular Diagnostics Inc. · INSMED Inc · Inspire Medical Systems, Inc. · InspireMD, Inc. · INSULET CORP · Integer Holdings Corp · INTEGRA LIFESCIENCES HOLDINGS CORP · INTEGRATED BIOPHARMA INC · Intellia Therapeutics, Inc. · INTELLIGENT BIO SOLUTIONS INC. · INTENSITY THERAPEUTICS, INC. · International Stem Cell CORP · INTERPACE BIOSCIENCES, INC. · INTUITIVE SURGICAL INC · Invivyd, Inc. · INVO Fertility, Inc. · IONIS PHARMACEUTICALS INC · IOVANCE BIOTHERAPEUTICS, INC. · IQVIA HOLDINGS INC. · IRADIMED CORP · iRhythm Holdings, Inc. · IRIDEX CORP · IRONWOOD PHARMACEUTICALS INC · Iterum Therapeutics plc · Jade Biosciences, Inc. · Jaguar Health, Inc. · Janux Therapeutics, Inc. · Jazz Pharmaceuticals plc · JOHNSON & JOHNSON · JOINT Corp · Journey Medical Corp · JUPITER NEUROSCIENCES, INC. · Jushi Holdings Inc. · Kailera Therapeutics, Inc. · KALA BIO, Inc. · Kalaris Therapeutics, Inc. · KalVista Pharmaceuticals, Inc. · KAMADA LTD · Kardigan, Inc. · Karyopharm Therapeutics Inc. · Keros Therapeutics, Inc. · KESTRA MEDICAL TECHNOLOGIES, LTD. · Kezar Life Sciences, Inc. · Kiniksa Pharmaceuticals International, plc · KIORA PHARMACEUTICALS INC · Klotho Neurosciences, Inc. · Korro Bio, Inc. · KORU Medical Systems, Inc. · Krystal Biotech, Inc. · Kura Oncology, Inc. · Kymera Therapeutics, Inc. · KYNTRA BIO, INC. · Kyverna Therapeutics, Inc. · LABCORP HOLDINGS INC. · LAKELAND INDUSTRIES INC · Lantern Pharma Inc. · Lantheus Holdings, Inc. · Larimar Therapeutics, Inc. · Latigo Biotherapeutics, Inc. · LAVA Therapeutics NV · Leef Brands Inc. · Legend Biotech Corp · LEMAITRE VASCULAR INC · LENSAR, Inc. · LENZ Therapeutics, Inc. · LeonaBio, Inc. · Lexaria Bioscience Corp. · Lexeo Therapeutics, Inc. · LEXICON PHARMACEUTICALS, INC. · LIFECORE BIOMEDICAL, INC. \DE\ · Lifeloc Technologies, Inc · LifeMD, Inc. · LifeStance Health Group, Inc. · Lifevantage Corp · Lifeward Ltd. · LIGAND PHARMACEUTICALS INC · Liminatus Pharma, Inc. · Lineage Cell Therapeutics, Inc. · Liquidia Corp · LISATA THERAPEUTICS, INC. · Lite Strategy, Inc. · LivaNova PLC · LIXTE BIOTECHNOLOGY HOLDINGS, INC. · LogicMark, Inc. · Longeveron Inc. · Lucid Diagnostics Inc. · LUDWIG ENTERPRISES, INC. · Lumexa Imaging Holdings, Inc. · Lyell Immunopharma, Inc. · Lyra Therapeutics, Inc. · MACROGENICS INC · MADRIGAL PHARMACEUTICALS, INC. · MAIA Biotechnology, Inc. · MANGOCEUTICALS, INC. · MANNATECH INC · MANNKIND CORP · MapLight Therapeutics, Inc. · MARAVAI LIFESCIENCES HOLDINGS, INC. · MARIMED INC. · Marpai, Inc. · MASIMO CORP · Matinas BioPharma Holdings, Inc. · MAXCYTE, INC. · Maze Therapeutics, Inc. · MBX Biosciences, Inc. · MCKESSON CORP · MDxHealth SA · MEDICINOVA INC · Medicus Pharma Ltd. · MediWound Ltd. · Medline Inc. · Medpace Holdings, Inc. · Medtronic plc · MeiraGTx Holdings plc · Merck & Co., Inc. · MERIT MEDICAL SYSTEMS INC · Mersana Therapeutics, Inc. · Merus N.V. · MESOBLAST LTD · Metagenomi Therapeutics, Inc. · MetaVia Inc. · Metsera, Inc. · METTLER TOLEDO INTERNATIONAL INC/ · Milestone Pharmaceuticals Inc. · MILESTONE SCIENTIFIC INC. · MIMEDX GROUP, INC. · Mind Medicine (MindMed) Inc. · Mineralys Therapeutics, Inc. · MiniMed Group, Inc. · MiNK Therapeutics, Inc. · Mirum Pharmaceuticals, Inc. · Mobia Medical, Inc. · Moderna, Inc. · Modular Medical, Inc. · Moleculin Biotech, Inc. · MOLINA HEALTHCARE, INC. · Monopar Therapeutics · Monte Rosa Therapeutics, Inc. · MoonLake Immunotherapeutics · Mountain Crest Acquisition Corp. V · MSA Safety Inc · Mural Oncology plc · MUSTANG BIO, INC. · MYOMO, INC. · MYRIAD GENETICS INC · Nano-X Imaging Ltd. · Nasus Pharma Ltd · Natera, Inc. · NATIONAL HEALTHCARE CORP · NATIONAL RESEARCH CORP · National Vision Holdings, Inc. · NATURAL ALTERNATIVES INTERNATIONAL INC · NATURES SUNSHINE PRODUCTS INC · Nautilus Biotechnology, Inc. · NEKTAR THERAPEUTICS · NEONC TECHNOLOGIES HOLDINGS, INC. · NEPHROS INC · Neumora Therapeutics, Inc. · Neuphoria Therapeutics Inc. · NEUROCRINE BIOSCIENCES INC · Neurogene Inc. · Neuronetics, Inc. · NEUROONE MEDICAL TECHNOLOGIES Corp · NeuroPace Inc · NeuroSense Therapeutics Ltd. · NewAmsterdam Pharma Co N.V. · NewcelX Ltd. · NewGenIvf Group Ltd · Nexentis Technologies Inc. · NEXGEL, INC. · NextCure, Inc. · Niagen Bioscience, Inc. · Nkarta, Inc. · NovaBridge Biosciences · NOVAVAX INC · NovoCure Ltd · NU SKIN ENTERPRISES, INC. · Nu-Med Plus, Inc. · Nuo Therapeutics, Inc. · Nurix Therapeutics, Inc. · Nutex Health Inc. · NUTRA PHARMA CORP · Nuvalent, Inc. · Nuvation Bio Inc. · Nuvectis Pharma, Inc. · Ocugen, Inc. · OCULAR THERAPEUTIX, INC · Odyssey Therapeutics, Inc. · OKYO Pharma Ltd · Olema Pharmaceuticals, Inc. · Omada Health, Inc. · OMEROS CORP · OmniAb, Inc. · Oncology Institute, Inc. · ONCOLYTICS BIOTECH INC · Onconetix, Inc. · Oncotelic Therapeutics, Inc. · OnKure Therapeutics, Inc. · OPKO HEALTH, INC. · OptimizeRx Corp · Option Care Health, Inc. · Opus Genetics, Inc. · ORAGENICS INC · ORAMED PHARMACEUTICALS INC. · ORASURE TECHNOLOGIES INC · Orchestra BioMed Holdings, Inc. · Organogenesis Holdings Inc. · Organon & Co. · Oric Pharmaceuticals, Inc. · ORTHOPEDIATRICS CORP · Oruka Therapeutics, Inc. · Oscar Health, Inc. · Outlook Therapeutics, Inc. · Ovid Therapeutics Inc. · OWENS & MINOR INC/VA/ · Owlet, Inc. · P3 Health Partners Inc. · PACIFIC BIOSCIENCES OF CALIFORNIA, INC. · PACIFIC HEALTH CARE ORGANIZATION INC · Pacira BioSciences, Inc. · PACS Group, Inc. · PALATIN TECHNOLOGIES INC · PALVELLA THERAPEUTICS, INC. · Parabilis Medicines, Inc. · Park Dental Partners, Inc. · Pasithea Therapeutics Corp. · Passage BIO, Inc. · PAVmed Inc. · Pediatrix Medical Group, Inc. · Pelthos Therapeutics Inc. · Pennant Group, Inc. · Penumbra Inc · PepGen Inc. · PERRIGO Co plc · Personalis, Inc. · Perspective Therapeutics, Inc. · PETMED EXPRESS INC · Petros Pharmaceuticals, Inc. · PetVivo Holdings, Inc. · PFIZER INC · PharmaCyte Biotech, Inc. · Pharvaris N.V. · Phathom Pharmaceuticals, Inc. · PHIBRO ANIMAL HEALTH CORP · Phreesia, Inc. · PLIANT THERAPEUTICS, INC. · Pluri Inc. · PLUS THERAPEUTICS, INC. · PMV Pharmaceuticals, Inc. · Polaryx Therapeutics, Inc. · Polyrizon Ltd. · Praxis Precision Medicines, Inc. · PRECIGEN, INC. · Precipio, Inc. · PRECISION OPTICS CORPORATION, INC. · Prelude Therapeutics Inc · Prenetics Global Ltd · Prestige Consumer Healthcare Inc. · Privia Health Group, Inc. · PRO DEX INC · PROCEPT BioRobotics Corp · Processa Pharmaceuticals, Inc. · Profusa, Inc. · Progyny, Inc. · PROKIDNEY CORP. · ProMIS Neurosciences Inc. · ProQR Therapeutics N.V. · Protagenic Therapeutics, Inc. ew · Protagonist Therapeutics, Inc · Protalix BioTherapeutics, Inc. · Protara Therapeutics, Inc. · PTC THERAPEUTICS, INC. · Pulmonx Corp · PULSE BIOSCIENCES, INC. · Pulsenmore Ltd. · PUMA BIOTECHNOLOGY, INC. · Q/C TECHNOLOGIES, INC. · Q32 Bio Inc. · QHSLab, Inc. · QT IMAGING HOLDINGS, INC. · Quanterix Corp · Quantum Cyber N.V. · Quantum-Si Inc · QUEST DIAGNOSTICS INC · QuidelOrtho Corp · Quince Therapeutics, Inc. · Quipt Home Medical Corp. · Quoin Pharmaceuticals, Ltd. · RadNet, Inc. · Rafael Holdings, Inc. · Rallybio Corp · Rani Therapeutics Holdings, Inc. · RAPID MICRO BIOSYSTEMS, INC. · Rapport Therapeutics, Inc. · RAPT Therapeutics, Inc. · RECURSION PHARMACEUTICALS, INC. · RedHill Biopharma Ltd. · REGENERON PHARMACEUTICALS, INC. · REGENXBIO Inc. · REGIONAL HEALTH PROPERTIES, INC · Rein Therapeutics, Inc. · Relay Therapeutics, Inc. · RELMADA THERAPEUTICS, INC. · RenovoRx, Inc. · Repare Therapeutics Inc. · REPLIGEN CORP · Replimune Group, Inc. · Research Alliance Corp III · RESMED INC · RETRACTABLE TECHNOLOGIES INC · REVELATION BIOSCIENCES, INC. · Revolution Medicines, Inc. · REVVITY, INC. · Rezolute, Inc. · RHYTHM PHARMACEUTICALS, INC. · Ridgetech Inc. · RIGEL PHARMACEUTICALS INC · ROCKET PHARMACEUTICALS, INC. · ROCKWELL MEDICAL, INC. · Roivant Sciences Ltd. · Royalty Pharma plc · RxSight, Inc. · SAB Biotherapeutics, Inc. · Sagimet Biosciences Inc. · Salarius Pharmaceuticals, Inc. · Sana Biotechnology, Inc. · Sanara MedTech Inc. · SANGAMO THERAPEUTICS, INC · SANUWAVE Health, Inc. · Sarepta Therapeutics, Inc. · Savara Inc · SBC Medical Group Holdings Inc · Scholar Rock Holding Corp · Schrodinger, Inc. · SCIENTIFIC INDUSTRIES INC · Scienture Holdings, Inc. · Scilex Holding Co · Scinai Immunotherapeutics Ltd. · SciSparc Ltd. · Scribe Therapeutics, Inc. · SCYNEXIS INC · Seaport Therapeutics, Inc. · SeaStar Medical Holding Corp · Seer, Inc. · SELECT MEDICAL HOLDINGS CORP · SELLAS Life Sciences Group, Inc. · Semler Scientific, Inc. · Semnur Pharmaceuticals, Inc. · Sensei Biotherapeutics, Inc. · Sensus Healthcare, Inc. · Senti Biosciences, Inc. · Septerna, Inc. · SERA PROGNOSTICS, INC. · Seres Therapeutics, Inc. · Serina Therapeutics, Inc. · Shattuck Labs, Inc. · SHOULDER INNOVATIONS, INC. · Shuttle Pharmaceuticals Holdings, Inc. · SI-BONE, Inc. · SIGA TECHNOLOGIES INC · Sight Sciences, Inc. · Silexion Therapeutics Corp · Silo Pharma, Inc. · Sintx Technologies, Inc. · Sionna Therapeutics, Inc. · Skye Bioscience, Inc. · Sol-Gel Technologies Ltd. · SOLENO THERAPEUTICS INC · Solid Biosciences Inc. · Solventum Corp · SONIDA SENIOR LIVING, INC. · Sonnet BioTherapeutics Holdings, Inc. · Sotera Health Co · Spectral AI, Inc. · Spero Therapeutics, Inc. · SPRUCE BIOSCIENCES, INC. · SpyGlass Pharma, Inc. · Spyre Therapeutics, Inc. · SS Innovations International, Inc. · STAAR SURGICAL CO · STANDARD BIOTOOLS INC. · Stereotaxis, Inc. · STERIS plc · Stevanato Group S.p.A. · Stimcell Energetics Inc. · Stoke Therapeutics, Inc. · Strata Critical Medical, Inc. · STRATA Skin Sciences, Inc. · Structure Therapeutics Inc. · STRYKER CORP · Summit Therapeutics Inc. · Sunshine Biopharma Inc. · SUPERNUS PHARMACEUTICALS, INC. · Surgery Partners, Inc. · SURMODICS INC · Surrozen, Inc./DE · SUTRO BIOPHARMA, INC. · Syndax Pharmaceuticals Inc · Synergy CHC Corp. · SYNLOGIC, INC. · TACTILE SYSTEMS TECHNOLOGY INC · TAKEDA PHARMACEUTICAL CO LTD · Talkspace, Inc. · TALPHERA, INC. · TANDEM DIABETES CARE INC · Tango Therapeutics, Inc. · Tarsus Pharmaceuticals, Inc. · Taysha Gene Therapies, Inc. · Tectonic Therapeutic, Inc. · TELA Bio, Inc. · Teladoc Health, Inc. · TELEFLEX INC · Telix Pharmaceuticals Ltd · Telomir Pharmaceuticals, Inc. · Tempest Therapeutics, Inc. · Tempus AI, Inc. · TENAX THERAPEUTICS, INC. · Tenaya Therapeutics, Inc. · TENET HEALTHCARE CORP · Tenon Medical, Inc. · Terns Pharmaceuticals, Inc. · TEVA PHARMACEUTICAL INDUSTRIES LTD · Tevogen Bio Holdings Inc. · TG THERAPEUTICS, INC. · TherapeuticsMD, Inc. · Theravance Biopharma, Inc. · THERMO FISHER SCIENTIFIC INC. · Tilray Brands, Inc. · Tiziana Life Sciences Ltd · Tonix Pharmaceuticals Holding Corp. · Tourmaline Bio, Inc. · Transcode Therapeutics, Inc. · TransMedics Group, Inc. · Travere Therapeutics, Inc. · Traws Pharma, Inc. · TREACE MEDICAL CONCEPTS, INC. · Trevi Therapeutics, Inc. · TriSalus Life Sciences, Inc. · Trulieve Cannabis Corp. · TRUPANION, INC. · TScan Therapeutics, Inc. · TuHURA Biosciences, Inc./NV · Turn Therapeutics Inc. · Twist Bioscience Corp · Tyra Biosciences, Inc. · U S PHYSICAL THERAPY INC /NV · UFP TECHNOLOGIES INC · Ultragenyx Pharmaceutical Inc. · uniQure N.V. · UNITED THERAPEUTICS Corp · UNITEDHEALTH GROUP INC · UNIVERSAL HEALTH SERVICES INC · Universe Pharmaceuticals INC · Upstream Bio, Inc. · UroGen Pharma Ltd. · USANA HEALTH SCIENCES INC · UTAH MEDICAL PRODUCTS INC · Valion Bio, Inc. · Vanda Pharmaceuticals Inc. · Varex Imaging Corp · Vaxart, Inc. · Vaxcyte, Inc. · Ventyx Biosciences, Inc. · Venus Concept Inc. · Vera Therapeutics, Inc. · VERACYTE, INC. · Veradermics, Inc · Verastem, Inc. · Veraxa Biotech AG - Post de-SPAC · Vericel Corp · Verrica Pharmaceuticals Inc. · VERTEX PHARMACEUTICALS INC / MA · VERU INC. · Viatris Inc · Vicarious Surgical Inc. · VIEMED HEALTHCARE, INC. · Viking Therapeutics, Inc. · Vir Biotechnology, Inc. · Vireo Growth Inc. · Viridian Therapeutics, Inc.\DE · Viskase Holdings, Inc. · Vistagen Therapeutics, Inc. · Vivani Medical, Inc. · Vivos Therapeutics, Inc. · VivoSim Labs, INC. · Vogenx, Inc. · VOLITIONRX LTD · Vor Biopharma Inc. · Voyager Therapeutics, Inc. · VSEE HEALTH, INC. · Warby Parker Inc. · WATERS CORP /DE/ · Wave Life Sciences Ltd. · WEED, INC. · Wellgistics Health, Inc. · Werewolf Therapeutics, Inc. · WEST PHARMACEUTICAL SERVICES INC · Whitehawk Therapeutics, Inc. · WORK Medical Technology Group LTD · X4 Pharmaceuticals, Inc · Xencor Inc · Xenetic Biosciences, Inc. · Xeris Biopharma Holdings, Inc. · Xilio Therapeutics, Inc. · XOMA Royalty Corp · Xtant Medical Holdings, Inc. · Yarrow Bioscience, Inc. · YD Bio Ltd · Zai Lab Ltd · Zenas BioPharma, Inc. · Zentalis Pharmaceuticals, Inc. · Zeo ScientifiX, Inc. · ZEVRA THERAPEUTICS, INC. · ZIMMER BIOMET HOLDINGS, INC. · ZimVie Inc. · Zivo Bioscience, Inc. · Zoetis Inc. · Zomedica Corp. · Zura Bio Ltd · Zymeworks Inc. · ZYNEX INC
Background
Price and liquidity context
median 30-day company return · 307 companies
median daily turnover
companies with buy / ADTV
Price movement is a descriptive comparison. Buy / ADTV is shown only when the insider value and turnover use the same currency; it is not an estimate of market impact.
Earnings-related buying
earnings events in 180 days
events followed by buying
median 5-day reaction
Observed patterns: EPS_MISS_DOWN_BUY (2) · NO_POST_EARNINGS_BUY (1)
Earnings surprise and price reaction are kept separate from insider activity. Missing estimates or event dates are not inferred.
Coverage and evidence quality
Eligible companies: 1029 · Buying companies: 42 · Price history: 307 · Complete purchase values: 42
Not available yet: outcomes after earlier buying (no archived snapshot has 20 days of prices after it yet).
A missing value is reported as unavailable and does not lower a signal. Source filing links remain the audit record.
Participation is not a return forecast. No sector score is added. Missing detail is not zero activity.
FDA healthcare events
Recent approved Drugs@FDA submissions, shown as research context. An approval is not automatically positive and does not affect Insider Signal.
Original approvals: 63 · Supplemental approvals: 270
| Date | Event | Product | Sponsor / applicant | Listed-company candidate | Application | Evidence |
|---|---|---|---|---|---|---|
| 2026-10-14 | Supplemental approval SUPPL 1 | LEUCOVORIN CALCIUM LEUCOVORIN CALCIUM | GLAND | — | ANDA218200 | FDA API ↗ |
| 2026-10-06 | New approval ORIG 1 | SOLRIAMFETOL SOLRIAMFETOL | AUROBINDO PHARMA LTD | — | ANDA218725 | FDA API ↗ |
| 2026-10-05 | Supplemental approval SUPPL 6 | TOPIRAMATE TOPIRAMATE | AJANTA PHARMA LTD | — | ANDA215663 | FDA API ↗ |
| 2026-10-02 | Supplemental approval SUPPL 3 | CYPROHEPTADINE HYDROCHLORIDE CYPROHEPTADINE HYDROCHLORIDE | QUAGEN | — | ANDA212491 | FDA API ↗ |
| 2026-09-25 | Supplemental approval SUPPL 64 | CLARITIN LORATADINE | BAYER HEALTHCARE LLC | — | NDA019658 | FDA API ↗ |
| 2026-09-24 | Supplemental approval SUPPL 6 | ARSENIC TRIOXIDE ARSENIC TRIOXIDE | NEXUS | — | ANDA209780 | FDA API ↗ |
| 2026-09-24 | Supplemental approval SUPPL 8 | ATOVAQUONE ATOVAQUONE | BIONPHARMA | — | ANDA212918 | FDA API ↗ |
| 2026-09-23 | Supplemental approval SUPPL 8 | HALOPERIDOL DECANOATE HALOPERIDOL DECANOATE | ZYDUS PHARMS | — | ANDA211180 | FDA API ↗ |
| 2026-09-22 | Supplemental approval SUPPL 4 | PREXXARTAN VALSARTAN | CARMEL BIOSCIENCES | — | NDA209139 | FDA API ↗ |
| 2026-09-18 | New approval ORIG 1 | DEFLAZACORT DEFLAZACORT | HIKMA | — | ANDA220524 | FDA API ↗ |
| 2026-09-17 | Supplemental approval SUPPL 5 | ICOSAPENT ETHYL ICOSAPENT ETHYL | APOTEX | — | ANDA209437 | FDA API ↗ |
| 2026-09-16 | Supplemental approval SUPPL 6 | TRUQAP CAPIVASERTIB | ASTRAZENECA | ASTRAZENECA PLC · AZN name match; review required | NDA218197 | FDA API ↗ |
| 2026-09-15 | Supplemental approval SUPPL 6 | TIGECYCLINE TIGECYCLINE | MEITHEAL | — | ANDA214020 | FDA API ↗ |
| 2026-09-08 | New approval ORIG 1 | IBRUTINIB IBRUTINIB | HETERO LABS LTD V | — | ANDA211182 | FDA API ↗ |
| 2026-08-20 | Supplemental approval SUPPL 8 | YESAFILI AFLIBERCEPT-JBVF | BIOCON BIOLOGICS INC | — | BLA761274 | FDA API ↗ |
| 2026-08-17 | Supplemental approval SUPPL 7 | FENOFIBRATE FENOFIBRATE | RISING | — | ANDA211122 | FDA API ↗ |
| 2026-08-11 | Supplemental approval SUPPL 19 | KAZANO ALOGLIPTIN BENZOATE, METFORMIN HYDROCHLORIDE | TAKEDA PHARMS USA | — | NDA203414 | FDA API ↗ |
| 2026-08-11 | Supplemental approval SUPPL 27 | ACTOPLUS MET METFORMIN HYDROCHLORIDE, PIOGLITAZONE HYDROCHLORIDE | TAKEDA PHARMS USA | — | NDA021842 | FDA API ↗ |
| 2026-08-11 | Supplemental approval SUPPL 7 | ACYCLOVIR ACYCLOVIR | RUBICON RESEARCH | — | ANDA215724 | FDA API ↗ |
| 2026-08-11 | Supplemental approval SUPPL 24 | DOXYCYCLINE HYCLATE DOXYCYCLINE HYCLATE | AMNEAL PHARMS | — | ANDA207289 | FDA API ↗ |
| 2026-08-11 | Supplemental approval SUPPL 18 | METFORMIN HYDROCHLORIDE METFORMIN HYDROCHLORIDE | ACTAVIS ELIZABETH | — | ANDA076878 | FDA API ↗ |
| 2026-08-10 | Supplemental approval SUPPL 8 | SCOPOLAMINE SCOPOLAMINE | MYLAN TECHNOLOGIES | — | ANDA203753 | FDA API ↗ |
| 2026-08-10 | Supplemental approval SUPPL 6 | SCOPOLAMINE SCOPOLAMINE | MYLAN TECHNOLOGIES | — | ANDA203753 | FDA API ↗ |
| 2026-07-31 | New approval ORIG 1 | THIAMINE HYDROCHLORIDE THIAMINE HYDROCHLORIDE | MANKIND PHARMA | — | ANDA220513 | FDA API ↗ |
| 2026-07-29 | New approval ORIG 1 | GLYCOPHOS SODIUM GLYCEROPHOSPHATE | FRESENIUS KABI USA | — | NDA220381 | FDA API ↗ |
Showing 25/333 retained approved events · captured 2026-10-18T22:56:00.741682+00:00
Interpretation rules
- Name matches are candidates only; a sponsor may be a subsidiary, contract manufacturer or unrelated entity.
- Supplemental approvals, labeling and manufacturing approvals are kept distinct from original applications.
- The current feed is an event index, not a clinical or commercial outcome forecast.
FDA drug safety and recall events
Recent FDA enforcement records are shown as risk context. Recall classification and status do not automatically imply a stock-price outcome or change the Insider Signal.
| Date | Classification | Firm | Product | Reason | Status | Listed-company candidate | Evidence |
|---|---|---|---|---|---|---|---|
| 2026-09-23 | Class II D-0877-2026 | Apotex Corp. | PAROXETINE HYDROCHLORIDE NDA020936 | Failed dissolution specifications. | Ongoing | — | FDA API ↗ |
| 2026-09-18 | Not Yet Classified | Aurobindo Pharma USA Inc | AMAZON BASIC CARE ACETAMINOPHEN M013 | Discoloration: consumer complaints received for discolored tablets | Ongoing | — | FDA API ↗ |
| 2026-09-17 | Class II D-0874-2026 | Aurolab Trust | FOCUS PI M018 | Lack of Assurance of Sterility | Ongoing | — | FDA API ↗ |
| 2026-09-17 | Class II D-0010-2027 | Ajanta Pharma USA Inc | RANOLAZINE ANDA210054 | Failed Dissolution Specifications: below specification | Ongoing | — | FDA API ↗ |
| 2026-09-15 | Class II D-0871-2026 | Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company | — | Lack of Assurance of Sterility | Ongoing | — | FDA API ↗ |
| 2026-09-15 | Class II D-0870-2026 | Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company | — | Lack of Assurance of Sterility | Ongoing | — | FDA API ↗ |
| 2026-09-14 | Not Yet Classified N/A | SUN PHARMACEUTICAL INDUSTRIES INC | NYSTATIN ANDA064022 | Failed Stability Specifications | Ongoing | — | FDA API ↗ |
| 2026-09-08 | Class II D-0876-2026 | Par Health USA, LLC | BUPRENORPHINE HYDROCHLORIDE ANDA206586 | Crystallization | Ongoing | — | FDA API ↗ |
| 2026-09-08 | Class II D-0873-2026 | Amneal Pharmaceuticals, LLC | ESTRADIOL ANDA216055 | Defective Container; packets were found to be either empty or partially full. | Ongoing | Amneal Pharmaceuticals, Inc. · AMRX name match; review required | FDA API ↗ |
| 2026-09-04 | Class II D-0853-2026 | Pfizer | DOPAMINE HYDROCHLORIDE NDA018132 | Lack of Assurance of Sterility | Ongoing | PFIZER INC · PFE name match; review required | FDA API ↗ |
| 2026-09-03 | Class II D-0864-2026 | OurPharma LLC | — | Labeling: Not Elsewhere Classified: Complaint received on 08/31/2026 regarding the discrepancy of the IV bag expiry (07/31/2026 and 11/30/2026) and the product expiry (12/09/2026). | Ongoing | — | FDA API ↗ |
| 2026-09-03 | Class II D-0852-2026 | Inventia Healthcare Limited | CHLORTHALIDONE ANDA211320 | Failed Dissolution Specifications | Ongoing | — | FDA API ↗ |
| 2026-09-01 | Class II D-0879-2026 | SV Labs Toronto Corporation | — | Microbial contamination of topical product. | Ongoing | — | FDA API ↗ |
| 2026-09-01 | Class II D-0878-2026 | SV Labs Toronto Corporation | — | Microbial contamination of topical product. | Ongoing | — | FDA API ↗ |
| 2026-08-31 | Class II D-0875-2026 | TerSera Therapeutics LLC | ZOLADEX NDA019726 | Temperature Abuse: Product sat in a non-temperature-controlled FedEx trailer at ambient outdoor conditions for 25.5 hours. | Ongoing | — | FDA API ↗ |
| 2026-08-31 | Class II D-0848-2026 | SUN PHARMA /TARO | LIDOCAINE ANDA086724 | Failed Content Uniformity Specifications. Out of Specification for Assay during analysis at the 24- month long term stability station, at (25¿C,60%RH). | Ongoing | — | FDA API ↗ |
| 2026-08-31 | Class III D-0833-2026 | Supernus Pharmaceuticals, Inc. | — | Failed dissolution specifications. | Ongoing | SUPERNUS PHARMACEUTICALS, INC. · SUPN name match; review required | FDA API ↗ |
| 2026-08-28 | Class II D-0868-2026 | Amneal Pharmaceuticals of New York, LLC | EXENATIDE ANDA206697 | Defective Delivery System: Possibility of no medication in the prefilled pen. | Ongoing | — | FDA API ↗ |
| 2026-08-27 | Class III D-0867-2026 | Macleods Pharmaceuticals Limited | OLANZAPINE ANDA202862 | Failed Impurities/Degradation Specifications:Organic and unspecified impurities above specification. | Ongoing | — | FDA API ↗ |
| 2026-08-26 | Class II D-0830-2026 | Mylan Pharmaceuticals Inc | MYCOPHENOLATE MOFETIL ANDA203859 | Failed Dissolution Specifications | Ongoing | — | FDA API ↗ |
| 2026-08-25 | Class III D-0836-2026 | Ajanta Pharma USA Inc | FLUPHENAZINE HYDROCHLORIDE ANDA217410 | Failed impurities/degradation specifications: (OOS) for Organic Impurities by HPLC (Impurity-A) during testing at the 18 months long term stability. Result: 1.1 percent. Spec: 1.0 percent. | Ongoing | — | FDA API ↗ |
| 2026-08-24 | Class III D-0835-2026 | ImprimisRx NJ LLC | — | Subpotent Drug | Ongoing | — | FDA API ↗ |
| 2026-08-24 | Class II D-0834-2026 | Teva Pharmaceuticals USA, Inc | TRAZODONE HYDROCHLORIDE ANDA071525 | Presence of Foreign Tablets/Capsules | Ongoing | — | FDA API ↗ |
| 2026-08-24 | Class II D-0831-2026 | Hikma Pharmaceuticals USA INC. | RAMIPRIL ANDA077900 | Failed Impurities/Degradation Specifications: OOS result obtained for a process impurity, dicyclohexylurea (DCU). | Ongoing | — | FDA API ↗ |
| 2026-08-21 | Class I D-0866-2026 | VITRUVIAS THERAPEUTICS INC | THYROID | Superpotent Drug | Ongoing | — | FDA API ↗ |
Showing 25/500 retained recall events.
Safety-event interpretation
- A recall is an event record; it is not a forecast of financial impact, liability or price direction.
- Listed-company candidates are name matches only and require issuer-level review.
- Enforcement and recall events are excluded from score calculation.
Market breadth & relative performance
Price participation, separate from insider buying.
Sector ETF performance
2026-10-16 · Price returns, excluding dividends. Smaller figures show excess over S&P 500 in percentage points.
| Sector / ETF | 1M | 3M | 6M |
|---|---|---|---|
| S&P 500 Price benchmark | +1.4% | +1.7% | +8.8% |
| HealthcareXLV | +5.3%+3.9 pp vs S&P | +9.2%+7.5 pp vs S&P | +20.5%+11.8 pp vs S&P |
ETF series coverage: 1/1 · ETF portfolios differ from this research universe.
Methodology & dates
Yahoo Finance close prices; complete matching sessions required. ETF holdings coverage has not been verified.
1M: 2026-09-16 → 2026-10-16 · 3M: 2026-07-16 → 2026-10-16 · 6M: 2026-04-16 → 2026-10-16
Constituent price coverage
19 / 1,029 companies have complete aligned 200-session history. Coverage is still building; these sample statistics cannot represent the whole sector.
View coverage and exploratory sample statistics
2026-10-16 · S&P 500 (^GSPC)
Above-MA percentages use companies with complete 50/200-session closes; coverage is shown against eligible issuers. Returns are equal-weight buy-and-hold price returns for the fully covered current-company sample, not a sector index. Dividends are excluded.
| Sector | MA50 | MA200 | 1M | 3M | 6M |
|---|---|---|---|---|---|
| Healthcare | 26.3% · 5/19 coverage 19/1029 | 31.6% · 6/19 coverage 19/1029 | -5.2% -6.6 pp 19/1029 | +5.4% +3.8 pp 19/1029 | +72.3% +63.5 pp 19/1029 |